8 min listen
Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction
Atorvastatin to Reduce Risk of Anthracycline-Associated Cardiac Dysfunction
ratings:
Length:
19 minutes
Released:
Aug 8, 2023
Format:
Podcast episode
Description
Anthracyclines are used to treat a variety of cancers, but treatment may be limited by cardiac toxicity. JAMA Executive Editor Gregory Curfman, MD, discusses a new clinical trial on the use of atorvastatin to prevent anthracycline-induced cardiac toxicity with authors Tomas Neilan, MD, MPH, and Marielle Scherrer-Crosbie, MD, PhD. Related Content: Atorvastatin for Anthracycline-Associated Cardiac Dysfunction
Released:
Aug 8, 2023
Format:
Podcast episode
Titles in the series (100)
Physician Communication in the 21st Century: Interview with Allan S. Detsky, MD, PhD, author of Physician Communication in the 21st Century by JAMA Author Interviews